ArticleJournal of experimental & clinical cancer research : CR2026

Circulating tumor DNA and Response Evaluation Criteria In Solid Tumors: ctDNA-RECIST proof-of-concept in HER2-positive metastatic breast cancer.

Alessandra Fabi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.